Mount Sinai’s Targeted Healthcare Innovation Fellowship (THRIVE)

Mar 1, 2021 | Conduits News

(THRIVE) Mount Sinai’s Targeted Healthcare Innovation Fellowship

Launched in October 2020 and supported by ConduITS Institute for Translational Sciences at the Icahn School of Medicine at Mount Sinai (CTSA), THRIVE is Mount Sinai’s Targeted Healthcare Innovation Fellowship, a brand new 9-month program for participants from diverse professional backgrounds to develop HealthTech innovations related to COVID-19.

The program is designed to provide an experiential team science platform for participants to take an idea from concept to commercial viable innovation. Following a competitive application process, 16 participants were selected to participate in the program.

THRIVE offers a one-of-a-kind opportunity to work in the MedTech innovation space, supported by top researchers leading the field in addressing COVID-19 head-on. Develop team science skills by collaborating with other talented and motivated trainees. The chance to take an idea from concept to through to commercially viable innovation. Application support to major innovation programs inside and outside of Mount Sinai such as the regional I-Corps Node (NYCRIN), ELab NYC, NYC Media Lab, Mid-Atlantic BioAngels, and Mount Sinai Pitch Challenge.

In the fall semester, participants attended weekly BioDesign webinars, hearing from innovators at Mount Sinai who have worked on projects related to COVID-19. A range of video resources is available as part of the program on the ISMMS YouTube page here: THRIVE Precision Recovery – YouTube

Participants also attended MSIP Bootcamp sessions with expert advisors. At the end of the fall semester, 3 self-selected teams had formed around common interests and diverse expertise. Teams selected a final project each to work on, developed an initial pitch document and recruited advisors and mentors.

The three teams are currently working on the following projects:

Vir2U: This app aims to increases the quality of epidemiological data tracking with quality risk assessment for reopening strategies post-COVID 19 by providing trusted data transparency for users and payees

Change Dx: The goals of this project are to develop a monitoring system to detect deviations in ED arrivals, in terms of patient case mix, disease distribution, and severity index quantified by Emergency Severity Index (ESI), using a change point detection algorithm

Lowe-Stocke: Inspired by PPE shortages at the start of the COVID-19 pandemic, this project aims to develop a system that improves supply chain intelligence for hospitals and medical centers through better equipment tracking at ground level.

Now in the spring semester, participants are focusing creating a budget, developing a prototype, and continued refinement of a pitch and other materials (market, commercial strategy, etc.). Teams each have a small budget allocation to allow them to access tech consultant support or training. In addition, mentors are providing support for participation in Sinai Innovations and external innovation programs and competitions. Commercially relevant inventions are being disclosed to MSIP for further commercialization work. In this way, the THRIVE program hopes to continue to support teams well beyond the end of the yearly program.

We look forward to seeing the resulting innovations!

ConduITS is supported by grant UL1TR001433 from the National Center for Advancing Translational Sciences, National Institutes of Health.”

Recent ConduITS News

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization. i3 Prism i3 Prism is an early-stage...

read more

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more